1. Home
  2. UBXG vs INDP Comparison

UBXG vs INDP Comparison

Compare UBXG & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBXG
  • INDP
  • Stock Information
  • Founded
  • UBXG 2018
  • INDP 2000
  • Country
  • UBXG China
  • INDP United States
  • Employees
  • UBXG N/A
  • INDP N/A
  • Industry
  • UBXG
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBXG
  • INDP Health Care
  • Exchange
  • UBXG Nasdaq
  • INDP Nasdaq
  • Market Cap
  • UBXG 11.8M
  • INDP 10.2M
  • IPO Year
  • UBXG 2024
  • INDP N/A
  • Fundamental
  • Price
  • UBXG $3.43
  • INDP $0.84
  • Analyst Decision
  • UBXG
  • INDP Strong Buy
  • Analyst Count
  • UBXG 0
  • INDP 2
  • Target Price
  • UBXG N/A
  • INDP $8.50
  • AVG Volume (30 Days)
  • UBXG 63.7K
  • INDP 25.3K
  • Earning Date
  • UBXG 12-31-2024
  • INDP 03-12-2025
  • Dividend Yield
  • UBXG N/A
  • INDP N/A
  • EPS Growth
  • UBXG N/A
  • INDP N/A
  • EPS
  • UBXG N/A
  • INDP N/A
  • Revenue
  • UBXG $51,600,106.00
  • INDP N/A
  • Revenue This Year
  • UBXG N/A
  • INDP N/A
  • Revenue Next Year
  • UBXG N/A
  • INDP N/A
  • P/E Ratio
  • UBXG N/A
  • INDP N/A
  • Revenue Growth
  • UBXG N/A
  • INDP N/A
  • 52 Week Low
  • UBXG $0.26
  • INDP $0.81
  • 52 Week High
  • UBXG $35.44
  • INDP $3.10
  • Technical
  • Relative Strength Index (RSI)
  • UBXG N/A
  • INDP 39.07
  • Support Level
  • UBXG N/A
  • INDP $0.86
  • Resistance Level
  • UBXG N/A
  • INDP $1.06
  • Average True Range (ATR)
  • UBXG 0.00
  • INDP 0.08
  • MACD
  • UBXG 0.00
  • INDP 0.00
  • Stochastic Oscillator
  • UBXG 0.00
  • INDP 12.80

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: